Skip to main content
. 2021 Jun 5;10(6):e1287. doi: 10.1002/cti2.1287

Figure 2.

Figure 2

Immunohistochemical detection of pulmonary ILC and Th cells in COPD patients and controls. T‐BET/GATA3/RORγt in brown, CD3 in green and antibodies against CD20, CD56, CD68 and mast cell tryptase (exclusion cocktail) in black. Staining was performed in COPD GOLD II patients and smoking and never‐smoking controls. T‐BET+CD3ILC1 (in brown, blue arrow) and T‐BET+CD3+Th1 cells (in brown with green border, red arrow) negative for exclusion markers (a). GATA3+CD3ILC2 (blue arrow) and GATA3+CD3+Th2 cells (red arrow) negative for exclusion markers (b). RORγt+CD3ILC3 (blue arrow) and RORγt +CD3+Th17 cells (red arrow) negative for exclusion markers (c). Scale bar: 20 µm.